Singapore – Researchers from A*STAR’s Singapore Immunology Network (SIgN) have discovered that the Plasmodiu...
Singapore - When lung cancer has spread, or metastasized, to other parts of the body, standard chemotherapy offers ...
A team of pharmaceutical scientists at the National University of Singapore (NUS), together with clinicians from the Nat...
Mylan and Fujifilm Kyowa Kirin Biologics recently announced that the European Commission (EC) has granted mar...
Researchers from Jinan University in China have developed a smart photoacoustic imaging approach by using a combination ...
Celltrion, a leading biopharmaceutical company headquartered in Incheon, Korea has signed an ‘Incubation’ ag...
A multidisciplinary team of researchers at the National University of Singapore (NUS) has developed a portable, easy-to-...
A team of researchers from the University of British Columbia, Canada has isolated an enzyme in the gut that reliably co...
EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, has ...
A group of scientists at the University of Manchester, UK has developed the first non-antibiotic drug to successfully tr...
Singapore - The UK's National Institute for Health and Care Excellence rejected Roche's OCREVUS (ocrelizumab) for p...
Boehringer Ingelheim (BI) and Tsinghua University in Beijing have announced a collaboration aiming to research and devel...
Singapore - An international collaboration between Imperial College London, Singapore’s Duke-NUS Medical School an...
A translational research team led by the National University of Singapore (NUS) has harnessed CURATE.AI, a powerful arti...
Medytox has said that it has filed a biologics license application with the Taiwan Food and Drug Administration for the ...
Researchers from the University of New South Wales (UNSW Sydney) in Australia have used gold-plated nanoparticles to det...
Researchers at the Hebrew University of Jerusalem said they have developed a new biological drug that had a 50 percent c...
Korea-based ViroMed announced the acquisition of a plasmid DNA production facility in San Diego, California&n...
